Income Statement XtalPi Holdings Limited

Stocks

2228

KYG7S12M1051

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 04:08:30 2026-06-11 am EDT			5-day change	1st Jan Change
6.830 ^HKD	-2.01%		-12.44%	-27.80%

Jun. 10	XtalPi Signs Drug Development Agreement with Potential Value of Over $400 Million	MT
May. 29	XtalPi receives second payment from Dovetree under strategic collaboration	RE

d3b53a0.xgEqrqIZAhdX-3AuWfMUq6zTdx3chM9hy10xGm2167Y.8DB6nu1yU04vzT8aFct4zsulJVak3PdM_AkARS76iuexLFyY631kRyGWEw

Published financial data: XTALPI HOLDINGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	62.8M	133M	174M	266M	803M
Total Revenues	62.8M	133M	174M	266M	803M
Cost of Goods Sold, Total	27.42M	60.1M	108M	143M	243M
Gross Profit	35.38M	73.25M	66.85M	123M	559M
Selling General & Admin Expenses, Total	178M	296M	415M	551M	491M
R&D Expenses	202M	315M	443M	356M	569M
Other Operating Expenses	-16.42M	5.28M	-72.12M	-68.92M	-39.09M
Other Operating Expenses, Total	363M	616M	786M	838M	1.02B
Operating Income	-328M	-543M	-719M	-715M	-462M
Interest Expense, Total	-3.58M	-5.75M	-9.58M	-6.76M	-9.37M
Interest And Investment Income	14.06M	50.48M	103M	55.64M	118M
Net Interest Expenses	10.48M	44.73M	93.12M	48.88M	108M
Income (Loss) On Equity Invest.	-4.5M	-236K	-1.96M	-4.19M	-14.88M
Currency Exchange Gains (Loss)	9.43M	5.91M	-40.37M	-1.95M	-3.42M
EBT, Excl. Unusual Items	-312M	-493M	-668M	-672M	-372M
Gain (Loss) On Sale Of Investments	10.36M	-9.62M	-4.38M	25.28M	507M
Other Unusual Items	-1.84B	-936M	-1.23B	-868M	-
EBT, Incl. Unusual Items	-2.14B	-1.44B	-1.91B	-1.51B	135M
Income Tax Expense	-	-	-	-	779K
Earnings From Continuing Operations	-2.14B	-1.44B	-1.91B	-1.51B	135M
Net Income to Company	-2.14B	-1.44B	-1.91B	-1.51B	135M
Minority Interest	44K	110K	-8.06M	-1.74M	-10.83M
Net Income - (IS)	-2.14B	-1.44B	-1.91B	-1.52B	124M
Net Income to Common Incl Extra Items	-2.14B	-1.44B	-1.91B	-1.52B	124M
Net Income to Common Excl. Extra Items	-2.14B	-1.44B	-1.91B	-1.52B	124M
Per Share Items
Net EPS - Basic	-4.43	-2.97	-3.96	-0.79	0.03
Basic EPS - Continuing Operations	-4.43	-2.97	-3.96	-0.79	0.03
Basic Weighted Average Shares Outstanding	482M	484M	484M	1.93B	3.78B
Net EPS - Diluted	-4.43	-2.97	-3.96	-0.79	0.03
Diluted EPS - Continuing Operations	-4.43	-2.97	-3.96	-0.79	0.03
Diluted Weighted Average Shares Outstanding	482M	484M	484M	1.93B	3.99B
Normalized Basic EPS	-0.4	-0.64	-0.88	-0.22	-0.06
Normalized Diluted EPS	-0.4	-0.64	-0.88	-0.22	-0.06
Supplemental Items
EBITDA	-315M	-495M	-648M	-631M	-383M
EBITA	-328M	-543M	-719M	-715M	-461M
EBIT	-328M	-543M	-719M	-715M	-462M
EBITDAR	-	-	-	-	-376M
Effective Tax Rate - (Ratio)	-	-	-	-	0.58
Total Deferred Taxes	-	-	-	-	779K
Normalized Net Income	-195M	-308M	-426M	-422M	-243M
Interest on Long-Term Debt	1.88M	4.35M	8.03M	4.98M	3.15M
Supplemental Operating Expense Items
Marketing Expenses	19.37M	58.31M	73.71M	62.44M	149M
Selling and Marketing Expenses	40.85M	91.19M	119M	133M	81.17M
General and Administrative Expenses	137M	204M	296M	418M	410M
Research And Development Expense From Footnotes	213M	359M	481M	418M	569M
Net Rental Expense, Total	-	-	-	-	6.73M
Imputed Operating Lease Interest Expense	-	-	-	-	1.71M
Imputed Operating Lease Depreciation	-	-	-	-	5.02M
Stock-Based Comp., Other (Total)	22.48M	43.38M	88.43M	137M	124M
Total Stock-Based Compensation	22.48M	43.38M	88.43M	137M	124M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.52B	574M	711M	1.17B	2.57B
Short Term Investments	314M	2.55B	1.26B	160M	1.92B
Trading Asset Securities, Total	-	356M	863M	1.79B	2.57B
Total Cash And Short Term Investments	3.84B	3.48B	2.84B	3.11B	7.06B
Accounts Receivable, Total	30.72M	37.94M	38.51M	102M	155M
Other Receivables	16.26M	22.95M	19.76M	43.27M	53.71M
Notes Receivable	-	-	-	6.74M	8.35M
Total Receivables	46.98M	60.89M	58.26M	152M	217M
Prepaid Expenses	5.04M	14.53M	9.3M	24.51M	42.28M
Restricted Cash	12.75M	5.43M	2.34M	797K	17.99M
Other Current Assets, Total	17.05M	33.28M	37.89M	25.67M	127M
Total Current Assets	3.92B	3.6B	2.95B	3.32B	7.47B
Gross Property Plant And Equipment	289M	459M	691M	623M	662M
Accumulated Depreciation	-18.08M	-63.34M	-131M	-211M	-297M
Net Property Plant And Equipment	271M	396M	559M	411M	365M
Long-term Investments	170M	303M	468M	602M	2.14B
Goodwill	-	-	-	-	169M
Other Intangibles, Total	5.12M	6.68M	7.87M	7.74M	64.53M
Accounts Receivable Long-Term	-	-	-	-	6.79M
Other Long-Term Assets, Total	16.05M	13.89M	24.92M	18.25M	6.92M
Total Assets	4.38B	4.32B	4.01B	4.35B	10.22B
Liabilities
Accounts Payable, Total	10.57M	13.98M	13.65M	16.14M	62.28M
Accrued Expenses, Total	48.65M	69.91M	74.11M	95.54M	136M
Short-term Borrowings	-	36M	60M	51.9M	159M
Current Portion of Long-Term Debt	22.28M	-	-	-	12M
Current Portion of Leases	17.3M	24.25M	58.78M	31.96M	25.46M
Current Income Taxes Payable	2.49M	4.48M	4.26M	925K	2.86M
Unearned Revenue Current, Total	11.83M	16.64M	33.09M	22.67M	57.37M
Other Current Liabilities	47.75M	32.39M	53.47M	60.59M	50.89M
Total Current Liabilities	161M	198M	297M	280M	506M
Long-Term Debt	7.71B	9.32B	10.78B	-	175M
Long-Term Leases	81.67M	69.21M	137M	64.9M	70.6M
Unearned Revenue Non Current	30.64M	29.63M	32.04M	17.8M	28M
Deferred Tax Liability Non Current	-	-	-	-	7.45M
Other Non Current Liabilities	280K	8.64M	-	-	-
Total Liabilities	7.99B	9.63B	11.25B	362M	787M
Common Stock, Total	50K	50K	50K	237K	301K
Additional Paid In Capital	4.59M	4.59M	4.59M	-	-
Retained Earnings	-3.68B	-5.13B	-7.04B	-8.57B	-8.45B
Treasury Stock	-19K	-19K	-19K	-	-
Comprehensive Income and Other	70.05M	-206M	-232M	12.54B	17.83B
Total Common Equity	-3.61B	-5.33B	-7.27B	3.96B	9.38B
Minority Interest	5.39M	17.88M	26.17M	28.55M	47.16M
Total Equity	-3.6B	-5.31B	-7.24B	3.99B	9.43B
Total Liabilities And Equity	4.38B	4.32B	4.01B	4.35B	10.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	482M	484M	782M	3.41B	4.3B
ECS Total Common Shares Outstanding	482M	484M	782M	3.41B	4.3B
Book Value / Share	-7.48	-11.01	-9.29	1.16	2.18
Tangible Book Value	-3.61B	-5.33B	-7.28B	3.96B	9.15B
Tangible Book Value Per Share	-7.49	-11.02	-9.3	1.16	2.13
Total Debt	7.83B	9.45B	11.04B	149M	442M
Net Debt	4B	5.97B	8.2B	-2.96B	-6.62B
Debt Equivalent Oper. Leases	-	-	-	-	53.86M
Minority Interest, Total (Incl. Fin. Div)	5.39M	17.88M	26.17M	28.55M	47.16M
Equity Method Investments, Total	213K	18.71M	23.84M	25.84M	42.86M
Account Code - Inventory Valuation	-	-	3	3	3
Machinery, Total	73.24M	183M	261M	320M	353M
Full Time Employees	-	-	783	753	1.15K
Part Time Employees	-	-	-	56	102
Accumulated Allowance for Doubtful Accounts (Supple)	898K	1.77M	1.82M	2.85M	3.06M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-2.14B	-1.44B	-1.91B	-1.52B	124M
Depreciation & Amortization - CF	22.05M	65.34M	116M	136M	106M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	1.13M
Depreciation & Amortization, Total	22.05M	65.34M	116M	136M	107M
Amortization of Deferred Charges, Total - (CF)	1.08M	3.71M	5.68M	3.42M	8.13M
(Gain) Loss From Sale Of Asset	-978K	-118K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-9.25M	12.22M	-68.62M	-28.31M	-505M
Asset Writedown & Restructuring Costs	-	-	-	-	35.7M
(Income) Loss On Equity Investments - (CF)	4.5M	236K	1.96M	4.19M	14.88M
Stock-Based Compensation (CF)	22.48M	43.38M	88.43M	137M	124M
Other Operating Activities, Total	1.82B	907M	1.22B	823M	-27.5M
Change In Accounts Receivable	-44.59M	-24.94M	-2.5M	-90.83M	-60.31M
Change In Inventories	-	-	-	-	-101M
Change In Accounts Payable	47.62M	26.79M	8.33M	63.72M	79.52M
Change in Unearned Revenues	-165K	-8.03M	-14.68M	-30.96M	35.26M
Change in Other Net Operating Assets	16.86M	-16.23M	-4.61M	21.04M	-
Cash from Operations	-254M	-429M	-568M	-479M	-165M
Capital Expenditure	-161M	-193M	-124M	-58.11M	-71.41M
Sale of Property, Plant, and Equipment	3.88M	1.49M	84K	2K	28K
Cash Acquisitions	-	-	-	-	-224M
Sale (Purchase) of Intangible assets	-3.1M	-5.19M	-6.84M	-3.76M	-10.09M
Investment in Marketable and Equity Securities, Total	80.42M	-2.6B	727M	65.19M	-3.66B
Other Investing Activities, Total	8.91M	41.99M	139M	70.77M	20.87M
Cash from Investing	-70.47M	-2.76B	736M	74.09M	-3.95B
Short Term Debt Issued, Total	-	-	-	-	312M
Long-Term Debt Issued, Total	20M	25M	60M	61.9M	187M
Total Debt Issued	20M	25M	60M	61.9M	499M
Short Term Debt Repaid, Total	-16.2M	-22.28M	-36M	-70M	-205M
Long-Term Debt Repaid, Total	-6.2M	-11.33M	-48.33M	-51.78M	-36.97M
Total Debt Repaid	-22.4M	-33.61M	-84.33M	-122M	-242M
Issuance of Common Stock	6K	-	-	905M	5.32B
Issuance of Preferred Stock	2.48B	-	-	-	-
Other Financing Activities, Total	-1.68M	66.6M	-1.55M	-4.64M	-6.22M
Cash from Financing	2.48B	57.99M	-25.89M	840M	5.57B
Foreign Exchange Rate Adjustments	-59.07M	179M	-5.59M	19.98M	-47.91M
Net Change in Cash	2.09B	-2.95B	137M	455M	1.41B
Supplemental Items
Cash Interest Paid	1.68M	1.61M	1.55M	1.78M	6.22M
Levered Free Cash Flow	-	-445M	-328M	-315M	-225M
Unlevered Free Cash Flow	-	-442M	-322M	-311M	-219M
Change In Net Working Capital	-	16.2M	-47.54M	78.26M	87.74M
Net Debt Issued / Repaid	-2.4M	-8.61M	-24.33M	-59.88M	257M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	-7.8	-10.8	-10.69	-3.96
Return on Total Capital	-	-8.11	-11.32	-11.26	-4.12
Return On Equity %	-	32.28	30.38	93.25	2.01
Return on Common Equity	-	32.19	30.4	91.81	1.85
Margin Analysis
Gross Profit Margin %	56.34	54.93	38.32	46.33	69.67
SG&A Margin	283.26	221.66	237.89	206.93	61.18
EBITDA Margin %	-502.31	-371.19	-371.49	-236.98	-47.7
EBITA Margin %	-522.05	-407.17	-412.09	-268.27	-57.42
EBIT Margin %	-522.05	-407.17	-412.09	-268.27	-57.56
Income From Continuing Operations Margin %	-3.4K	-1.08K	-1.09K	-568.57	16.77
Net Income Margin %	-3.4K	-1.08K	-1.1K	-569.23	15.42
Net Avail. For Common Margin %	-3.4K	-1.08K	-1.1K	-569.23	15.42
Normalized Net Income Margin	-310.88	-230.77	-243.98	-158.29	-30.31
Levered Free Cash Flow Margin	-	-333.95	-188.14	-118.2	-27.99
Unlevered Free Cash Flow Margin	-	-331.26	-184.71	-116.62	-27.26
Asset Turnover
Asset Turnover	-	0.03	0.04	0.06	0.11
Fixed Assets Turnover	-	0.4	0.37	0.55	2.07
Receivables Turnover (Average Receivables)	-	3.88	4.56	3.78	6.24
Short Term Liquidity
Current Ratio	24.37	18.2	9.9	11.85	14.77
Quick Ratio	24.15	17.93	9.74	11.65	14.38
Operating Cash Flow to Current Liabilities	-1.58	-2.17	-1.91	-1.71	-0.33
Days Sales Outstanding (Average Receivables)	-	93.95	79.98	96.73	58.45
Average Days Payable Outstanding	-	74.56	46.88	38.13	58.79
Long Term Solvency
Total Debt/Equity	-217.36	-177.98	-152.41	3.73	4.69
Total Debt / Total Capital	185.21	228.24	290.81	3.59	4.48
LT Debt/Equity	-216.26	-176.84	-150.77	1.63	2.6
Long-Term Debt / Total Capital	184.27	226.79	287.68	1.57	2.49
Total Liabilities / Total Assets	182.25	223.02	280.77	8.32	7.7
EBIT / Interest Expense	-91.7	-94.5	-75.07	-105.78	-49.3
EBITDA / Interest Expense	-85.54	-83.12	-62.95	-85.65	-37.83
(EBITDA - Capex) / Interest Expense	-130.45	-116.78	-75.88	-94.25	-45.46
Total Debt / EBITDA	-25.62	-19.79	-18.31	-0.26	-1.25
Net Debt / EBITDA	-13.07	-12.49	-13.6	5.12	18.67
Total Debt / (EBITDA - Capex)	-16.8	-14.08	-15.19	-0.23	-1.04
Net Debt / (EBITDA - Capex)	-8.57	-8.89	-11.28	4.65	15.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	112.35	30.8	52.75	201.25
Gross Profit, 1 Yr. Growth %	-	107.05	-8.75	155.85	353.05
EBITDA, 1 Yr. Growth %	-	56.92	30.9	-8.59	-39.36
EBITA, 1 Yr. Growth %	-	65.62	32.38	-6.14	-35.52
EBIT, 1 Yr. Growth %	-	65.62	32.38	-6.14	-35.37
Earnings From Cont. Operations, 1 Yr. Growth %	-	-32.69	32.51	-20.53	-108.88
Net Income, 1 Yr. Growth %	-	-32.69	33.08	-20.78	-108.16
Normalized Net Income, 1 Yr. Growth %	-	57.63	38.28	-6.75	-42.32
Diluted EPS Before Extra, 1 Yr. Growth %	-	-32.93	33.23	-80.05	-103.8
Accounts Receivable, 1 Yr. Growth %	-	23.5	1.5	165.76	51.21
Net Property, Plant and Equip., 1 Yr. Growth %	-	46.22	41.33	-26.44	-11.35
Total Assets, 1 Yr. Growth %	-	-1.5	-7.19	8.71	134.63
Tangible Book Value, 1 Yr. Growth %	-	47.58	36.39	-154.38	131.3
Common Equity, 1 Yr. Growth %	-	47.61	36.41	-154.54	136.74
Cash From Operations, 1 Yr. Growth %	-	69.11	32.27	-15.66	-65.44
Capital Expenditures, 1 Yr. Growth %	-	20.45	-36	-53.06	22.89
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-26.31	-11.25	-28.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-27.07	-10.94	-29.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	66.66	41.35	114.52
Gross Profit, 2 Yr. CAGR %	-	-	37.45	29.8	240.46
EBITDA, 2 Yr. CAGR %	-	-	43.32	12.94	-25.55
EBITA, 2 Yr. CAGR %	-	-	48.07	14.73	-22.21
EBIT, 2 Yr. CAGR %	-	-	48.07	14.73	-22.11
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-5.56	2.62	-73.43
Net Income, 2 Yr. CAGR %	-	-	-5.36	2.68	-74.58
Normalized Net Income, 2 Yr. CAGR %	-	-	47.64	17.07	-26.66
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-5.47	-48.45	-91.3
Accounts Receivable, 2 Yr. CAGR %	-	-	11.96	64.24	100.46
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	43.76	1.96	-19.25
Total Assets, 2 Yr. CAGR %	-	-	-4.39	0.45	59.71
Tangible Book Value, 2 Yr. CAGR %	-	-	41.87	-13.88	12.15
Common Equity, 2 Yr. CAGR %	-	-	41.9	-13.74	13.63
Cash From Operations, 2 Yr. CAGR %	-	-	49.56	5.62	-46.01
Capital Expenditures, 2 Yr. CAGR %	-	-	-12.2	-45.19	-24.05
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-15.91	-20.44
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-16.13	-20.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	61.89	81.9
Gross Profit, 3 Yr. CAGR %	-	-	-	51.66	96.9
EBITDA, 3 Yr. CAGR %	-	-	-	26.02	-8.21
EBITA, 3 Yr. CAGR %	-	-	-	29.67	-5.32
EBIT, 3 Yr. CAGR %	-	-	-	29.67	-5.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-10.84	-54.6
Net Income, 3 Yr. CAGR %	-	-	-	-10.81	-55.86
Normalized Net Income, 3 Yr. CAGR %	-	-	-	29.27	-7.54
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-43.72	-78.39
Accounts Receivable, 3 Yr. CAGR %	-	-	-	49.35	59.78
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	14.98	-2.68
Total Assets, 3 Yr. CAGR %	-	-	-	-0.21	33.28
Tangible Book Value, 3 Yr. CAGR %	-	-	-	3.06	19.71
Common Equity, 3 Yr. CAGR %	-	-	-	3.17	20.77
Cash From Operations, 3 Yr. CAGR %	-	-	-	23.56	-27.22
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-28.74	-28.26
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-20.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-20.88